vs

Side-by-side financial comparison of GOLD RESOURCE CORP (GORO) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

GOLD RESOURCE CORP is the larger business by last-quarter revenue ($51.3M vs $37.2M, roughly 1.4× Organogenesis Holdings Inc.). On growth, GOLD RESOURCE CORP posted the faster year-over-year revenue change (295.5% vs -57.1%). Over the past eight quarters, GOLD RESOURCE CORP's revenue compounded faster (65.6% CAGR vs -46.5%).

Gold Springs Resource Corp is a Canadian company that is pursuing the development of the Gold Springs gold-silver mine on the border of Utah and Nevada in the United States. Headquartered in Vancouver, the company is listed on the Toronto Stock Exchange in Canada and the OTCQX market exchange in the US. The company was founded in 2006 as the South American Silver Corporation, an equity carve-out of the General Minerals Corporation, to pursue exploration and development of the Malku Khota and ...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

GORO vs ORGO — Head-to-Head

Bigger by revenue
GORO
GORO
1.4× larger
GORO
$51.3M
$37.2M
ORGO
Growing faster (revenue YoY)
GORO
GORO
+352.6% gap
GORO
295.5%
-57.1%
ORGO
Faster 2-yr revenue CAGR
GORO
GORO
Annualised
GORO
65.6%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GORO
GORO
ORGO
ORGO
Revenue
$51.3M
$37.2M
Net Profit
$18.0M
Gross Margin
51.5%
30.8%
Operating Margin
38.9%
-185.1%
Net Margin
35.1%
Revenue YoY
295.5%
-57.1%
Net Profit YoY
261.6%
EPS (diluted)
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GORO
GORO
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$51.3M
$225.6M
Q3 25
$24.9M
$150.9M
Q2 25
$11.2M
$101.0M
Q1 25
$12.4M
$86.7M
Q4 24
$13.0M
$126.7M
Q3 24
$13.3M
$115.2M
Q2 24
$20.8M
$130.2M
Net Profit
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
$18.0M
$43.7M
Q3 25
$-4.7M
$21.6M
Q2 25
$-11.5M
$-9.4M
Q1 25
$-8.3M
$-18.8M
Q4 24
$-11.1M
$7.7M
Q3 24
$-12.7M
$12.3M
Q2 24
$-27.0M
$-17.0M
Gross Margin
GORO
GORO
ORGO
ORGO
Q1 26
30.8%
Q4 25
51.5%
Q3 25
25.0%
Q2 25
-39.4%
Q1 25
-11.8%
72.6%
Q4 24
-46.7%
75.5%
Q3 24
-65.3%
76.7%
Q2 24
-17.3%
77.6%
Operating Margin
GORO
GORO
ORGO
ORGO
Q1 26
-185.1%
Q4 25
38.9%
28.1%
Q3 25
-14.9%
13.7%
Q2 25
-102.4%
-12.5%
Q1 25
-63.1%
-30.9%
Q4 24
-96.9%
8.1%
Q3 24
-122.7%
5.4%
Q2 24
-52.1%
-10.7%
Net Margin
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
35.1%
19.4%
Q3 25
-18.7%
14.3%
Q2 25
-102.3%
-9.3%
Q1 25
-67.3%
-21.7%
Q4 24
-85.9%
6.1%
Q3 24
-95.5%
10.7%
Q2 24
-129.9%
-13.1%
EPS (diluted)
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
$0.14
$0.31
Q3 25
$-0.03
$0.11
Q2 25
$-0.09
$-0.10
Q1 25
$-0.07
$-0.17
Q4 24
$-0.11
$0.05
Q3 24
$-0.14
$0.09
Q2 24
$-0.30
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GORO
GORO
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$25.0M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$44.0M
Total Assets
$184.1M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GORO
GORO
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$25.0M
$93.7M
Q3 25
$9.8M
$63.7M
Q2 25
$12.7M
$73.1M
Q1 25
$4.9M
$110.0M
Q4 24
$1.6M
$135.6M
Q3 24
$1.4M
$94.3M
Q2 24
$5.3M
$89.9M
Total Debt
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
$44.0M
$300.1M
Q3 25
$26.0M
$255.1M
Q2 25
$19.2M
$233.2M
Q1 25
$24.6M
$242.9M
Q4 24
$27.3M
$262.9M
Q3 24
$37.9M
$278.5M
Q2 24
$49.8M
$263.5M
Total Assets
GORO
GORO
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$184.1M
$598.7M
Q3 25
$164.3M
$509.8M
Q2 25
$155.1M
$461.1M
Q1 25
$147.7M
$467.4M
Q4 24
$145.9M
$497.9M
Q3 24
$154.5M
$446.3M
Q2 24
$161.5M
$443.2M
Debt / Equity
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GORO
GORO
ORGO
ORGO
Operating Cash FlowLast quarter
$24.2M
Free Cash FlowOCF − Capex
$15.3M
FCF MarginFCF / Revenue
29.8%
Capex IntensityCapex / Revenue
17.3%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$644.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
$24.2M
$39.4M
Q3 25
$-325.0K
$3.1M
Q2 25
$-1.3M
$-32.9M
Q1 25
$-828.0K
$-19.9M
Q4 24
$1.3M
$10.9M
Q3 24
$-3.4M
$8.7M
Q2 24
$-63.0K
$4.7M
Free Cash Flow
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
$15.3M
$34.8M
Q3 25
$-7.8M
$844.0K
Q2 25
$-3.8M
$-36.5M
Q1 25
$-3.0M
$-23.6M
Q4 24
$58.0K
$7.6M
Q3 24
$-5.7M
$6.1M
Q2 24
$-2.1M
$2.9M
FCF Margin
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
29.8%
15.4%
Q3 25
-31.3%
0.6%
Q2 25
-34.2%
-36.1%
Q1 25
-24.4%
-27.2%
Q4 24
0.4%
6.0%
Q3 24
-43.1%
5.3%
Q2 24
-10.0%
2.2%
Capex Intensity
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
17.3%
2.1%
Q3 25
30.0%
1.5%
Q2 25
22.6%
3.6%
Q1 25
17.7%
4.2%
Q4 24
9.8%
2.7%
Q3 24
17.7%
2.2%
Q2 24
9.7%
1.4%
Cash Conversion
GORO
GORO
ORGO
ORGO
Q1 26
Q4 25
1.34×
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons